SOD deficiency has been shown to drive amyloid β protein oligomerization and promote plaque formation and hyperphosphorylation of tau in transgenic mouse models of AD (Li et al., 2004; Melov et al., 2007; Murakami et al., 2011), which are also generally recognized as important mechanisms for PSCI. This evidence concerns the gene SOD1 and Alzheimer disease.